Catalyst Wire Dossier Catalyst Wire Dossier

SP-002

· Stamford Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SP-002, covering 2024-09-20 to 2024-09-20. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma [Phase 2]

See pricing